REJOICE-Ovarian01 Phase 2/3 Trial of Raludotatug Deruxtecan Initiated in Patients with Platinum-Resistant Ovarian Cancer

US takes next step in Medicare drug price negotiations with pharma companies

Profitability is next sacrifice at inflation altar

Why Merck (MRK) is a Top Momentum Stock for the Long-Term

Why Merck (MRK) is a Top Momentum Stock for the Long-Term

Merck to Hold First-Quarter 2024 Sales and Earnings Conference Call April 25

Merck & Co., Inc.'s (NYSE:MRK) Intrinsic Value Is Potentially 98% Above Its Share Price

Merck (MRK) Rises Higher Than Market: Key Facts

Merck (MRK) Rises Higher Than Market: Key Facts

Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

How We Can Strengthen Vaccination Programs and Build Vaccine Confidence Together

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Company News for Mar 28, 2024

Company News for Mar 28, 2024

European Commission Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy as Neoadjuvant Treatment, Then Continued as Monotherapy as Adjuvant Treatment, for Resectable Non-Small Cell Lung Cancer (NSCLC) at High Risk of Recurrence in Adults

POINT MARCHÉS Records en vue en Europe pour la dernière séance du trimestre

Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and Merck & Company (MRK)

US STOCKS-Stocks close with gains, led by Dow as investors look for rate insight